[1] Virani SS, Alonso A, Benjamin EJ, et al.Heart disease and stroke statistics-2020 update: a report from the american heart association[J]. Circulation, 2020,141(9): e139-e596.
[2] China cardiovascular health and disease report writing group. 2019 summary of China cardiovascular health and disease report[J].Chinese Circulation Journal, 2020, 35(9): 833-854.(in Chinese)
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2019概要[J]. 中国循环杂志, 2020, 35(9): 833-854.
[3] Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204):1145-1158.
[4] Mathew SA, Naik C, Cahill PA, et al. Placental mesenchymal stromal cells as an alternative tool for therapeutic angiogenesis[J]. Cell Mol Life Sci,2020,77(2):253-265.
[5] Bosch-Marce M,Okuyama H,Wesley JB,et al. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia[J]. Circ Res, 2007, 101(12): 1310-1318.
[6] Russo V, Young S, Hamilton A, et al. Mesenchymal stem cell delivery strategies to promote cardiac regeneration following ischemic injury[J]. Biomaterials, 2014, 35(13): 3956-3974.
[7] Bianconi V, Sahebkar A, Kovanen P, et al. Endothelial and cardiac progenitor cells for cardiovascular repair:controversial paradigm in cell therapy[J]. Pharmacol Ther, 2018, 181:156-168.
[8] Li SH, Sun Z, Brunt KR, et al. Reconstitution of aged bone marrow with young cells repopulates cardiac-resident bone marrow-derived progenitor cells and prevents cardiac dysfunction after a myocardial infarction[J]. Eur Heart J, 2013, 34(15): 1157-1167.
[9] Li XQ, Bai ShL,Ao Q,et al. Effects of Klotho on the proliferation and differentiation of rat bone marrow mesenchymal stem cells[J].Acta Anatomica Sinica, 2019,50(6):729-734.(in Chinese)
李秀全,柏树令,敖强,等. Klotho对大鼠骨髓间充质干细胞增殖和分化的影响[J]. 解剖学报, 2019,50(6):729-734.
[10] Li Q,Zhu Z,Wang C,et al. CTRP9 ameliorates cellular senescence via PGC1α/AMPK signaling in mesenchymal stem cells[J]. Int J Mol Med, 201,42(2):1054-1063.
[11] Liang C,Liu Z,Song M,et al. Stabilization of heterochromatin by CLOCK promotes stem cell rejuvenation and cartilage regeneration[J]. Cell Res,2021,31(2): 187-205.
[12] Bi S,Wang H,Kuang W. Stem cell rejuvenation and the role of autophagy in age retardation by caloric restriction: an update[J]. Mech Ageing Dev,2018,175:46-54.
[13] Song HF,Guo R,Zhang L. Hypoxic preconditioning increases tolerant ability of old human bone marrow mesenchymal stem cells to oxidative stress injury through AKT pathway[J].Chinese Journal of Pathophysiology, 2016,32(5):912-916. (in Chinese)
宋慧芳,郭蕊,张亮. 低氧预处理通过激活AKT通路提高老年hBMMSCs对氧化应激损伤的耐受能力[J]. 中国病理生理杂志,2016,32(5):912-916
[14] Choi SH,Shin HW,Park JY,et al. Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines[J]. Korean J Hepatol,2010,16(3): 280-287.
[15] Yu X,Gao C,Dai C,et al. Endometrial injury increases expression of hypoxia-inducible factor and angiogenesis in the endometrium of women with recurrent implantation failure[J]. Reprod Biomed Online,2019,38(5): 761-767.
[16] Song HF, He S, Li SH, et al. Aged human multipotent mesenchymal stromal cells can be rejuvenated by neuron-derived neurotrophic factor and improve heart function after Injury[J]. JACC Basic Transl Sci, 2017,2(6):702-716.
[17] Jia SD,Yao Y,Song Y, et al. Two-year outcomes after left main coronary artery percutaneous coronary intervention in patients presenting with acute coronary syndrome[J]. J Interv Cardiol,2020,2020:6980324.
[18] Chen Z, Chen L, Zeng C, et al. Functionally improved mesenchymal stem cells to better treat myocardial infarction[J]. Stem Cells Int,2018,2018:7045245.
[19] Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease[J]. Circ Res,2011,109(8):923-940.
[20] Nurkovic J, Volarevic Ⅴ, Lako M, et al. Aging of stem and progenitor cells: mechanisms, impact on therapeutic potential, and rejuvenation[J]. Rejuvenation Res,2016,19(1):3-12.
[21] Khorraminejad-Shirazi M, Farahmandnia M, Kardeh B, et al.Aging and stem cell therapy: AMPK as an applicable pharmacological target for rejuvenation of aged stem cells and achieving higher efficacy in stem cell therapy[J]. Hematol Oncol Stem Cell Ther, 2018,11(4):189-194.
[22] Tekin D, Dursun AD, Xi L. Hypoxia inducible factor 1 (HIF-1) and cardioprotection[J]. Acta Pharmacol Sin, 2010,31(9):1085-1094.
[23] Cai Z, Manalo DJ, Wei G, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury[J]. Circulation,2003,108(1):79-85.
[24] Cao R, Br?kenhielm E, Pawliuk R, et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2[J]. Nat Med,2003,9(5):604-613.
[25] Hou J, Wang L, Long H, et al. Hypoxia preconditioning promotes cardiac stem cell survival and cardiogenic differentiation in vitro involving activation of the HIF-1α/apelin/APJ axis[J]. Stem Cell Res Ther, 2017,8(1):215.
|